[Pharmacologic modification of reperfusion injury].
Miura
M
M
Second Department of Internal Medicine, Akita University School of Medicine.
Kobayashi
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005466:Fluorocarbons / Q000627:therapeutic use; D005609:Free Radicals / Q000378:metabolism; D005978:Glutathione / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D013482:Superoxide Dismutase / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D005466:Fluorocarbons; D005609:Free Radicals; C050455:fluosol; D013482:Superoxide Dismutase; D005978:Glutathione; D008274:Magnesium; D002118:Calcium